IVDR IVDR QMS Supplemented

HX 1782924-1

Manufacturer: QIAGEN GmbH
Basic UDI-DIs
0
Scopes
5
Preceding Certs
1
Risk Classes
2
Characteristics
0
Revision
Rev. 4
20
Expires in 20 days
Expiry: June 29, 2026

Basic Information

Number
HX 1782924-1
Type
IVDR QMS
Legislation
IVDR
Issue Date
September 13, 2024
Expiry Date
June 29, 2026
Revision
Rev. 4
Manufacturer
QIAGEN GmbH

Certificate Lifecycle

September 13, 2024 June 29, 2026

Scopes

5 scopes covering 2 risk classes

Quality Procedure Scope

Device Group Class C

GENETIC TESTING IVR 0301 Devices intended to be used in screening, diagnosis, staging or monitoring of cancer W01060299 - TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER

Quality Procedure Scope

Device Group Class C

INFECTIOUS DISEASES IVR 0503 Devices intended to be used to detect the presence of, or exposure to an infectious agent including sexually transmitted agents W01050107 - Mycobacteria Genus + Species W01050705 - MULTIPLE PANELS FOR INFECTIONS - VARIOUS

Quality Procedure Scope

Device Group Class C

SAMPLES COLLECTION DEVICES IVR 0503 Devices intended to be used to detect the presence of, or exposure to an infectious agent including sexually transmitted agents W05010101 - Venous or Arterious Blood Collection Devices

Quality Procedure Scope

Device Group Class C

NUCLEIC ACID TESTING INSTRUMENTS IVR 0302 Other devices intended to be used for markers of cancer and non-malignant tumours IVR 0403 Other devices intended to be used for human genetic testing W02050192 – NUCLEIC ACID TESTING INSTRUMENTS EXCEPT MICRO-ARRAYS - IVD MEDICAL DEVICE SOFTWARE

Quality Procedure Scope

Device Group Class D

INFECTIOUS DISEASES IVR 0503 Devices intended to be used to detect the presence of, or exposure to an infectious agent including sexually transmitted agents W01050705 - MULTIPLE PANELS FOR INFECTIONS - VARIOUS

Preceding Certificates

HX 1782924-1 Supplemented
Issued: July 30, 2024 Expires: June 29, 2026

Basic UDI-DIs

This Certificate doesn't seem to be associated with any Basic UDI-DIs. If you think that sounds weird, so do we. But that's what the EUDAMED data seems to state.